Cite
HARVARD Citation
Neumann, J. et al. (n.d.). The natural anticancer compound rocaglamide selectively inhibits the G1‐S‐phase transition in cancer cells through the ATM/ATR‐mediated Chk1/2 cell cycle checkpoints. International journal of cancer. 134 (8), pp. 1991-2002. [Online].